Ipamorelin × Synerium Peptides — lab test, June 2026
COA DFG-8DL matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
DFG-8DLTest results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 5 mg · Lab measured 6.17 mg
123% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 1.5 mg using the measured mass, against 1.3 mg on the label — 23% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | DFG-8DL |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Ipamorelin from Synerium Peptides, performed by Uzorak on June 26, 2026. Reported purity: 99.71%. Net content: 6.17 mg against 5 mg labeled (123% of label). Tested content exceeds the labeled amount by 23%. Batch Sr-202601-025. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion